Hot search: steel  management  news  company  David  Process  Chain  Eric  Company,  Hong 
 
Home > News > Industries > Content

Avedro Landed a CE Mark in The European Union for Its Non-Surgical Myopia Treatment Device

increase font size  reduce font Add date: 2016-11-30  Hits:56
Core prompt: Avedro (Waltham, MA) landed a CE Mark in the European Union for its non-surgical myopia treatment device. The device, dubbed KXL II, can perform a photorefractive intrastro

Avedro (Waltham, MA) landed a CE Mark in the European Union for its non-surgical myopia treatment device. The device, dubbed KXL II, can perform a photorefractive intrastromal cross-linking procedure, allowing for the correction of myopia. In addition, the device can be used to improve outcomes for cataract surgery.

In March, Avedro raised $43 million in a funding round. That round was led by Abingworth and Third Point.

"The KXL II and PiXL procedure continue our mission to make refractive correction truly non-surgical. Treating myopia and other refractive disorders with PiXL has the potential to open up refractive correction to millions of people who have never considered Lasik surgery before, but would consider a non-surgical alternative," stated CEO David Muller.

Avedro is a privately-held company that manufactures a variety of pharmaceuticals and medical devices. The KXL and some of the company’s pharmaceuticals are currently being used in Phase III clinical trials in the United States.

 
 
[ NewsSearch ]  [ Send Fav ]  [ Share ]  [ Print ]  [ Send Report ]  [ Close ]

 
Total0bar [View All]  Related Comments

 
Photo Recommended
Recommend News
Click Rank
 
Home | Products | Suppliers | News | Tradeshow | Sitemap | Message | RSS Feed